特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

子宮頸がん診断検査の世界市場

Cervical Cancer Diagnostic Testing

発行 Global Industry Analysts, Inc. 商品コード 938819
出版日 ページ情報 英文 181 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

子宮頸がん診断検査の世界市場 Cervical Cancer Diagnostic Testing
出版日: 2020年07月01日 ページ情報: 英文 181 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

世界の子宮頸がん診断検査の市場は、新型コロナウイルス感染症 (COVID-19) の世界的流行とそれに伴う経済不況の中、予測期間中4.9%のCAGRで推移すると予測されています。検査区分別では、子宮頚部細胞診の部門が同期間中4.2%を超えるCAGRで成長する見通しです。歴史上例のないCOVID-19の大流行は、あらゆる産業にかつて経験したことのない様々な影響を及ぼしています。子宮頚部細胞診の部門も、ポストCOVID-19時代に向けたニューノーマル(新常態)を構築することとなるでしょう。新たなシナリオで見ると、地域別では、米国が3.9%のCAGRで推移する見通しです。欧州の中で大流行の影響を大きく受けたドイツの市場規模は、今後7-8年で6890万米ドルを超える規模の拡大を示す見通しです。また他の欧州地域では、7060万米ドルを超える規模の需要が見込まれています。一方、日本の子宮頚部細胞診の市場は予測期間末までに2億9420万米ドルの市場規模に成長する見通しです。また、今回の大流行の発端となり深刻な政治的および経済的課題に直面する中国は、さまざまな障壁にもかかわらず、今後数年間で8.1%の成長を示す見通しです。

調査対象企業の例

  • Abbott Laboratories
  • Arbor Vita Corporation
  • AutoGenomics, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • BioVantra, LLC
  • Cancer Genetics, Inc.
  • Cepheid, Inc.
  • Cytoimmun Diagnostics GmbH
  • Daan Gene Co., Ltd.
  • DiaCarta, Inc.
  • F. Hoffmann-La Roche AG
  • Fujirebio, Inc.
  • Genera Biosystems Ltd.
  • Greiner Bio-One International GmbH
  • Guided Therapeutics, Inc.
  • GynaeHealth
  • Hologic, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Institute
  • OralDNA Labs
  • PreTect AS
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.
  • Roche Molecular Diagnostics
  • Rovers Medical Devices
  • Seegene, Inc.
  • Solopap Australia
  • TrovaGene, Inc.

当レポートでは、世界の子宮頸がん診断検査の市場を調査し、市場および製品の概要、市場成長への各種影響因子の分析、市場規模の推移と予測、各種区分・地域・主要国別の詳細分析、競合環境、主要企業プロファイルなどをまとめています。

I イントロダクション・調査手法・調査範囲

II エグゼクティブサマリー

第1章 市場概要

  • 世界の企業シェア
  • 企業シェアシナリオ
  • Covid-19の影響・景気後退の見通し

第2章 主要企業

第3章 市場動向・成長推進因子

第4章 世界市場の展望

III 市場分析

  • 市場分析:地域・主要国別

IV 競合

  • 企業プロファイル
目次
Product Code: MCP10982

Global Cervical Cancer Diagnostic Testing Market to Reach $8.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Cervical Cancer Diagnostic Testing estimated at US$5.9 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Pap Smear Test, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$5.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the HPV Testing segment is readjusted to a revised 6.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 7.4% CAGR

The Cervical Cancer Diagnostic Testing market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.We bring years of research experience to this 9th edition of our report. The 181-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Arbor Vita Corporation
  • AutoGenomics, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • BioVantra, LLC
  • Cancer Genetics, Inc.
  • Cepheid, Inc.
  • Cytoimmun Diagnostics GmbH
  • Daan Gene Co., Ltd.
  • DiaCarta, Inc.
  • F. Hoffmann-La Roche AG
  • Fujirebio, Inc.
  • Genera Biosystems Ltd.
  • Greiner Bio-One International GmbH
  • Guided Therapeutics, Inc.
  • GynaeHealth
  • Hologic, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Institute
  • OralDNA Labs
  • PreTect AS
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.
  • Roche Molecular Diagnostics
  • Rovers Medical Devices
  • Seegene, Inc.
  • Solopap Australia
  • TrovaGene, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Cervical Cancer Diagnostic Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Cervical Cancer Diagnostic Testing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Cervical Cancer Diagnostic Testing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Cervical Cancer Diagnostic Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Pap Smear Test (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Pap Smear Test (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Pap Smear Test (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: HPV Testing (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: HPV Testing (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: HPV Testing (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cervical Cancer Diagnostic Testing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 10: United States Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 11: Cervical Cancer Diagnostic Testing Market in the United States by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 12: United States Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 13: Canadian Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 14: Canadian Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 15: Cervical Cancer Diagnostic Testing Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
  • JAPAN
    • TABLE 16: Japanese Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 17: Cervical Cancer Diagnostic Testing Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 18: Japanese Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 19: Chinese Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 20: Cervical Cancer Diagnostic Testing Historic Market Analysis in China in US$ Million by Test Type: 2012-2019
    • TABLE 21: Chinese Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Cervical Cancer Diagnostic Testing Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 22: European Cervical Cancer Diagnostic Testing Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 23: Cervical Cancer Diagnostic Testing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 24: European Cervical Cancer Diagnostic Testing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 25: European Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 26: Cervical Cancer Diagnostic Testing Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 27: European Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 28: Cervical Cancer Diagnostic Testing Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 29: French Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 30: French Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 31: Cervical Cancer Diagnostic Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 32: German Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 33: German Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 34: Italian Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 35: Cervical Cancer Diagnostic Testing Historic Market Analysis in Italy in US$ Million by Test Type: 2012-2019
    • TABLE 36: Italian Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 38: Cervical Cancer Diagnostic Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 39: United Kingdom Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 40: Spanish Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 41: Spanish Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 42: Cervical Cancer Diagnostic Testing Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
  • RUSSIA
    • TABLE 43: Russian Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 44: Cervical Cancer Diagnostic Testing Market in Russia by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 45: Russian Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 47: Cervical Cancer Diagnostic Testing Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 48: Rest of Europe Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 50: Cervical Cancer Diagnostic Testing Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 51: Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 52: Cervical Cancer Diagnostic Testing Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 53: Asia-Pacific Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 54: Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • AUSTRALIA
    • TABLE 55: Cervical Cancer Diagnostic Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 56: Australian Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 57: Australian Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 58: Indian Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 59: Indian Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 60: Cervical Cancer Diagnostic Testing Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
  • SOUTH KOREA
    • TABLE 61: Cervical Cancer Diagnostic Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 62: South Korean Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 63: Cervical Cancer Diagnostic Testing Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 65: Cervical Cancer Diagnostic Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 66: Rest of Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 67: Latin American Cervical Cancer Diagnostic Testing Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 68: Cervical Cancer Diagnostic Testing Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 69: Latin American Cervical Cancer Diagnostic Testing Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 70: Latin American Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 71: Cervical Cancer Diagnostic Testing Historic Market Analysis in Latin America in US$ Million by Test Type: 2012-2019
    • TABLE 72: Latin American Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • ARGENTINA
    • TABLE 73: Argentinean Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 74: Cervical Cancer Diagnostic Testing Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 75: Argentinean Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 76: Cervical Cancer Diagnostic Testing Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 77: Brazilian Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 78: Brazilian Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • MEXICO
    • TABLE 79: Cervical Cancer Diagnostic Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 80: Mexican Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 81: Mexican Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 83: Cervical Cancer Diagnostic Testing Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 84: Rest of Latin America Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 85: The Middle East Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 86: Cervical Cancer Diagnostic Testing Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 87: The Middle East Cervical Cancer Diagnostic Testing Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 88: The Middle East Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 89: The Middle East Cervical Cancer Diagnostic Testing Historic Market by Test Type in US$ Million: 2012-2019
    • TABLE 90: Cervical Cancer Diagnostic Testing Market in the Middle East: Percentage Share Breakdown of Sales by Test Type for 2012,2020, and 2027
  • IRAN
    • TABLE 91: Iranian Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 92: Cervical Cancer Diagnostic Testing Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 93: Iranian Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 94: Israeli Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 95: Cervical Cancer Diagnostic Testing Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 96: Israeli Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 98: Cervical Cancer Diagnostic Testing Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012-2019
    • TABLE 99: Saudi Arabian Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED ARAB EMIRATES
    • TABLE 100: Cervical Cancer Diagnostic Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 101: United Arab Emirates Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 102: Cervical Cancer Diagnostic Testing Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 103: Cervical Cancer Diagnostic Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 104: Rest of Middle East Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 105: Rest of Middle East Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 106: African Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 107: Cervical Cancer Diagnostic Testing Market in Africa by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 108: African Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 43